| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Vera Therapeutics, Inc. (VERA) have been net sellers, shedding 37,000 shares worth roughly $1.3M on balance.
Counted by filing, the last 12 months brought 1 open-market purchase by 1 insider worth about $250K and 18 sales by 8 insiders worth about $9.0M. The 12 months before that brought 1 open-market purchase by 1 insider worth about $5.3M and 6 sales by 1 insider worth about $5.3M.
9 of the 18 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
The largest open-market purchase in the last two years was 250,000 shares by Patrick G Enright (Director) at an average $21.11 on June 24, 2025, about $5.3M. Three months later VERA was up 16%.
The most recent purchase was by Patrick G Enright (Director) on December 11, 2025.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.2K | $7.22M | - | |
| CFO | 114.2K | $3.51M | - | |
| VP | 80.8K | $2.48M | - | |
| Other | 64.2K | $1.97M | - | |
| Other | 50.9K | $1.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Marshall Fordyce74 | President and CEO | Sale+OE10b5-1 | 18,500 | $37.00 | $684,500.00 | -7.3% | - | - | |
| Sep 2, 2026 | Marshall Fordyce74 | President and CEO | Sale+OE10b5-1 | 18,500 | $35.12 | $649,642.30 | -7.3% | - | - | |
| Jul 7, 2026 | Marshall Fordyce74 | President and CEO | Sell10b5-1 | 46,250 | $42.30 | $1,956,187.12 | -23.3% | -30.6% | - | |
| Jun 23, 2026 | Marshall Fordyce74 | President and CEO | Sell10b5-1 | 18,500 | $37.93 | $701,769.25 | -8.5% | -10.3% | - | |
| May 12, 2026 | Marshall Fordyce74 | President and CEO | Sell10b5-1 | 18,500 | $36.74 | $679,747.06 | -7.9% | -14.0% | - | |
| Apr 14, 2026 | Marshall Fordyce74 | President and CEO | Sell10b5-1 | 22,951 | $44.05 | $1,011,050.80 | -8.9% | -6.4% | - | |
| Feb 23, 2026 | Laurence Matthew Skelton | Chief Commercial Officer | Sell | 1,582 | $41.98 | $66,418.53 | -2.4% | -18.4% | - | |
| Feb 23, 2026 | William D. Turner60 | Chief Regulatory Officer | Sell | 2,187 | $41.98 | $91,818.79 | -4.6% | -18.4% | - | |
| Feb 23, 2026 | Joseph R Young61 | SVP, Finance, Chief Acct Officer | Sell | 3,117 | $41.98 | $130,863.82 | -4.6% | -18.4% | - | |
| Feb 23, 2026 | David Lee Johnson | Chief Operating Officer | Sell | 2,579 | $41.98 | $108,276.48 | -5.3% | -18.4% | - |